August 13, 2017 by
Dr. Gang Song is a genomics innovator and co-founder of Pillar Biosciences, who co-invented Pillar Biosciences’ SLIMamp™ technology. He subsequently founded Affyimmune Therapeutics, a cellular immunotherapy company. Previously, Dr. Song was a Technical Lead at Integrated Genetics, LabCorp (previously Genzyme Genetics), and prior to that, was a Project Lead at IQuum before its acquisition by Roche Molecular Diagnostics. Dr. Song completed his postdoctoral training in Timothy Springer's lab at Harvard Medical School and received his PhD from Shanghai Medical College of Fudan University, China.